UNSPSC 51152111: Dicyclomine/phenobarbital

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA802. This VA Drug Class (GA802) classifies this compound as belonging to the group ANTIMUSCARINIC/ANTIPASMODIC COMBINATIONS.

UNSPSC 51152111 Dicyclomine/phenobarbital is a Commodity code, but the recent state and local opportunities tagged under it do not reflect pharmaceutical products matching the code's nominal scope. Instead, the two recent solicitations target naloxone procurement and direct-to-manufacturer prescription program management — neither of which align with dicyclomine/phenobarbital purchasing. The mismatch suggests the code receives limited relevant activity in state and local procurement databases, or that tagging accuracy for pharmaceutical commodities in this tier is inconsistent across jurisdictional procurement systems.

The two posted opportunities show activity from a Florida county health department and the Texas Health and Human Services Commission. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building in Sanford, with a bid deadline of July 26, 2023. The Texas HHS Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescription program — an exploratory information-gathering phase to inform future state contracting strategy rather than a formal competitive solicitation. Neither opportunity reflects dicyclomine/phenobarbital demand. State and local buyers pursuing pharmaceutical inventory — particularly controlled substances and emergency-response medications — should monitor this code for accuracy, as recent tagging does not support reliable sourcing intelligence under the code's nominal scope.